(0.27%) 5 113.90 points
(0.34%) 38 370 points
(0.34%) 15 982 points
(-1.47%) $82.62
(5.51%) $2.03
(0.32%) $2 354.60
(0.18%) $27.59
(3.97%) $958.75
(-0.20%) $0.933
(-0.35%) $10.99
(-0.53%) $0.796
(1.68%) $93.41
-0.94% INR 99.75
Live Chart Being Loaded With Signals
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications...
Stats | |
---|---|
Dagens volum | 21 825.00 |
Gjennomsnittsvolum | 135 245 |
Markedsverdi | 1.58B |
EPS | INR0 ( 2024-02-13 ) |
Last Dividend | INR0.500 ( 2017-12-21 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -13.93 |
ATR14 | INR0.172 (0.17%) |
Volum Korrelasjon
Mangalam Drugs & Organics Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Mangalam Drugs & Organics Korrelasjon - Valuta/Råvare
Mangalam Drugs & Organics Økonomi
Annual | 2022 |
Omsetning: | INR3.70B |
Bruttogevinst: | INR1.20B (32.29 %) |
EPS: | INR0.800 |
FY | 2022 |
Omsetning: | INR3.70B |
Bruttogevinst: | INR1.20B (32.29 %) |
EPS: | INR0.800 |
FY | 2022 |
Omsetning: | INR4.47B |
Bruttogevinst: | INR1.36B (30.44 %) |
EPS: | INR12.42 |
FY | 2021 |
Omsetning: | INR3.80B |
Bruttogevinst: | INR1.24B (32.66 %) |
EPS: | INR17.67 |
Financial Reports:
No articles found.
Mangalam Drugs & Organics Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.200 | 2005-08-30 |
Last Dividend | INR0.500 | 2017-12-21 |
Next Dividend | INR0 | N/A |
Payout Date | 2017-12-29 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | INR2.90 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.48 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 2.16 | |
Div. Directional Score | 0.784 | -- |
Year | Amount | Yield |
---|---|---|
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0 | 0.00% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
THOMASCOOK.NS | Dividend Junior | 2023-08-10 | Sporadic | 18 | 0.15% | |
ORIENTPPR.NS | Dividend Junior | 2023-08-01 | Annually | 18 | 1.07% | |
ISGEC.NS | Dividend Junior | 2023-08-14 | Annually | 4 | 0.27% | |
CYBERTECH.NS | Dividend Junior | 2023-09-22 | Annually | 18 | 0.77% | |
SHREECEM.NS | Dividend Junior | 2023-06-01 | Annually | 23 | 0.25% | |
MARKSANS.NS | Dividend Junior | 2023-06-07 | Annually | 11 | 0.40% | |
GRINDWELL.NS | Dividend Junior | 2023-08-03 | Annually | 18 | 0.77% | |
BALMLAWRIE.NS | Dividend Knight | 2023-09-20 | Annually | 23 | 3.62% | |
POONAWALLA.NS | Dividend Junior | 2023-07-18 | Sporadic | 21 | 0.21% | |
JTLIND.NS | Dividend Junior | 2023-08-04 | Insufficient data to determine frequency | 2 | 0.04% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0473 | 1.500 | -0.945 | -1.418 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.119 | 1.500 | -2.44 | -3.66 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -0.541 | 1.000 | -1.312 | -1.312 | [3 - 30] |
operatingCashFlowPerShareTTM | 17.10 | 2.00 | 4.30 | 8.60 | [0 - 30] |
freeCashFlowPerShareTTM | 17.10 | 2.00 | 1.448 | 2.90 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.286 | 1.000 | 8.57 | 8.57 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0202 | 1.000 | -2.40 | -2.40 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.593 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -9.41 | 1.000 | -1.052 | 0 | [1 - 100] |
returnOnEquityTTM | -0.119 | 2.50 | -1.568 | -3.66 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 17.10 | 2.00 | 4.30 | 2.90 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 17.10 | 2.00 | 4.30 | 8.60 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.883 | 1.500 | 7.45 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0753 | 1.000 | -0.617 | 0 | [0.1 - 0.5] |
Total Score | 2.16 |
Mangalam Drugs & Organics
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.